Q: Teach me this A: Now I have everything I need. Here is a full teaching session on everything in your slides: --- Neonatal Jaundice - Complete Teaching Guide What Is Neonatal Jaundice? Jaundice hyperbilirubinemia in newborns is yellow discolouration caused by accumulation of unconjugated bilirubin in the skin and sclerae. The newborn liver is immature and cannot process bilirubin efficiently for the first week of life. --- Why Does It Matter? Unconjugated bilirubin is lipid soluble - it crosses the blood-brain barrier and deposits in basal ganglia/brainstem nuclei causing kernicterus bilirubin encephalopathy = permanent brain damage. This is what you're trying to prevent. --- Causes by Timing Exam Table Timing Key Causes ------------------- 24 hours Always pathological - ABO/Rh haemolysis, congenital infection 2-3 days Physiological jaundice most common 3 days - 1 week Sepsis, UTI, G6PD deficiency, Crigler-Najjar 1 week Breast milk jaundice, biliary atresia, hypothyroidism, metabolic --- The AMC Question: 4-Day Baby, Total Bilirubin 380, Conjugated = 12 Key reasoning chain: 1. Day 4 of life 2. Total bilirubin = 380 µmol/L very high 3. Conjugated bilirubin = 12 µmol/L low - so this is predominantly unconjugated 4. Conjugated Bil. is NOT elevated, so this is NOT biliary atresia or hepatitis Correct answer: Phototherapy option 2 Why not exchange transfusion? Because the slide's second graph below shows that on Day 4, phototherapy threshold is 350-450 µmol/L. At 380, you START with phototherapy - exchange transfusion comes only if bilirubin keeps rising despite phototherapy, or if it exceeds the exchange transfusion threshold 425-500+ at Day 4 for an infant at lower risk. --- The Two Critical Treatment Graphs Graph 1 - Phototherapy Thresholds !Phototherapy guidelines for infants ≥35 weeks gestationhttps://cdn.orris.care/cdssimages/a0ae12c8076f98f013b24895960bc202df4e6c98ef1f8cd72b5b4f3714d4c238.png Three risk lines: - Lower risk blue - 38 weeks gestation, well baby - Medium risk green - 38 weeks + risk factors, OR 35-37 weeks + well - Higher risk red - 35-37 weeks + risk factors Risk factors include: isoimmune haemolytic disease, G6PD deficiency, asphyxia, lethargy, temperature instability, sepsis, acidosis, albumin 3.0 g/dL At Day 4 96 hours: - Lower risk threshold: 18 mg/dL 308 µmol/L - Higher risk threshold: 15 mg/dL 257 µmol/L Graph 2 - Exchange Transfusion Thresholds !Exchange transfusion guidelines for infants ≥35 weeks gestationhttps://cdn.orris.care/cdssimages/d7f7321441c11e7f77b7f6203c89865eace0657d36ec561d5f0e7f6204ebb410.png Exchange transfusion thresholds sit approximately 5 mg/dL 85 µmol/L ABOVE the phototherapy thresholds. Immediate exchange transfusion don't wait if the infant shows signs of acute bilirubin encephalopathy: - Hypertonia - Arching/retrocollis - Opisthotonus - High-pitched cry - Fever --- Treatment Decision Framework Memory Aid Bilirubin Rising → Below phototherapy line? → Monitor, feed well, follow up Above phototherapy line? → START PHOTOTHERAPY Rising despite phototherapy? → Consider exchange transfusion Above exchange line OR encephalopathy signs? → EXCHANGE TRANSFUSION NOW The slide's note: "Day 4 - phototherapy is between 350-450" means the phototherapy zone at Day 4 is approximately 350-450 µmol/L. At 380, you're within the phototherapy zone - start phototherapy, do NOT jump to exchange transfusion. --- Exchange Transfusion Thresholds by Age from your slide - for ≥35 weeks Age Higher Risk SBR µmol/L Medium Risk Lower Risk 38 wk, well --------------------------------------------------------------------- Birth 200 235 270 12 hrs 230 255 295 24 hrs 255 280 320 48 hrs 290 320 375 72 hrs 315 360 405 96 hrs 320 380 425 5-7 days 320 380 425 For low birthweight infants 1500g: thresholds are much lower 170-255 µmol/L even at 24h. --- Why Phototherapy Works Blue light wavelength 460-490 nm converts unconjugated bilirubin in the skin into water-soluble isomers lumirubin that can be excreted in bile and urine WITHOUT needing hepatic conjugation. It's non-invasive and very effective. --- Q2: 6-Year-Old Boy - Learning Difficulties + Congenital Heart Defect Clues in the question: - Difficulty learning since starting school 6 months ago - IQ = 86 borderline low, but not severe intellectual disability - Adopted with unknown history - Mild conductive hearing loss - Flat nasal bridge - Grade 3 holosystolic murmur on the left side of the heart likely VSD Correct answer: Karyotype analysis → Down syndrome Why Karyotype, not FMR1 DNA analysis Fragile X? Feature Down Syndrome Trisomy 21 Fragile X Syndrome ------------------------------------------------------ Cause Karyotype abnormality extra chromosome 21 FMR1 gene mutation CGG repeat expansion Diagnosis Karyotype / chromosomal microarray FMR1 DNA analysis Facial features Flat nasal bridge, epicanthal folds, small ears, upslanting palpebral fissures Long face, large prominent ears, prominent jaw Heart defect VSD, AVSD very common 40-50% Less commonly associated Hearing loss Conductive common - due to chronic ear infections Sensorineural or conductive Body build Short, stocky Tall, large body habitus "everything big" as the slide notes Intellect Mild-moderate intellectual disability Usually moderate intellectual disability in males The flat nasal bridge + VSD holosystolic murmur on left = VSD + conductive hearing loss + unknown history = classic Down syndrome presentation. The fact the child is adopted unknown history means antenatal screening was never done. Karyotype will show 47,XX or XY +21 trisomy 21 in 95% of Down syndrome cases. The remaining 5% are translocation or mosaic types - all detectable by karyotype. --- Summary - What To Remember for AMC Scenario Answer ------------------ Day 4, Total Bil. 380 µmol/L, Conj. Bil. 12 Phototherapy Bilirubin not responding to phototherapy Exchange transfusion Baby with acute encephalopathy signs opisthotonus, high-pitched cry Immediate exchange transfusion Child with flat nasal bridge, VSD, conductive hearing loss, learning difficulties Karyotype Down syndrome Child with large ears, large body, learning difficulties male FMR1 DNA analysis Fragile X Jaundice in first 24 hours Always pathological - think haemolysis Conjugated bilirubin elevated Always pathological - think biliary atresia The core principle running through all neonatal jaundice management is: escalate based on bilirubin level + gestational age + risk factors, with phototherapy as the first-line step and exchange transfusion reserved for failure or severe cases. For the genetics question, the physical exam clues flat nasal bridge, VSD point you directly toward Down syndrome and karyotyping.
